Literature DB >> 9274840

Glomerular ICAM-1 expression related to circulating TNF-alpha in human glomerulonephritis.

H Yokoyama1, M Takaeda, T Wada, S Ohta, Y Hisada, C Segawa, K Furuichi, K Kobayashi.   

Abstract

To clarify the in vivo involvement of cellular adhesion molecules and cytokines in human glomerulonephritis, we have investigated the glomerular and interstitial expression of intercellular adhesion molecule 1 (ICAM-1) in 69 kidney biopsy specimens by immunohistochemical methods and its correlation with serum bioactive tumor necrosis factor alpha (TNF-alpha) and soluble ICAM-1 (sICAM-1) levels in 43 cases. In normal controls, glomerular ICAM-1 expression and serum TNF-alpha and sICAM-1 levels showed a mean score of 1.0 (n = 7) and were 12.1 +/- 1.5 and 187 +/- 5 ng/ml (mean +/- SEM, n = 25), respectively. ICAM-1 was positive in 68 kidneys except in 1 patient with membranous nephropathy at various degrees in glomeruli and in 72% of peritubular capillaries or venules in the interstitium. Serum-bioactive TNF-alpha levels increased in the patients with IgA nephropathy, purpura nephritis, and lupus nephritis (LN) (18.9 +/- 4.1, 32.6 +/- 13.3, and 20.9 +/- 3.5 pg/ml) and were positively correlated with the grade of glomerular ICAM-1 expression (n = 43, r = 0.57, p < 0.001), endocapillary proliferation with exudative lesions (r = 0.72, p < 0.001) and hematuria (r = 0.62, p < 0.001). Serum sICAM-1 levels were elevated in patients with LN and purpura nephritis and decreased from 312 +/- 40 to 226 +/- 21 ng/ml after methylprednisolone pulse therapy in LN (n = 9, p = 0.0285). sICAM-1 levels were positively correlated with the grade of interstitial ICAM-1 expression (r = 0.46, p < 0.05), and sICAM-1 levels (>210 ng/ml) showed high odds ratios in the interstitial ICAM-1-positive cases and systemic vasculitides such as purpura nephritis and LN (6.00, p = 0.0355; 6.50, p = 0.0216, respectively). These results suggest that bioactive TNF-alpha might relate to glomerular ICAM-1 expression associated with endocapillary lesions in human glomerulonephritis and that sICAM-1 levels may be used as a clinical marker to assess interstitial lesions in human nephritis and systemic vasculitides.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9274840     DOI: 10.1159/000190225

Source DB:  PubMed          Journal:  Nephron        ISSN: 1660-8151            Impact factor:   2.847


  10 in total

1.  Absence of nicotinic acetylcholine receptor α7 subunit amplifies inflammation and accelerates onset of fibrosis: an inflammatory kidney model.

Authors:  Luan D Truong; Jessica Trostel; Gabriela E Garcia
Journal:  FASEB J       Date:  2015-05-18       Impact factor: 5.191

2.  Increased urinary levels of the leukocyte adhesion molecules ICAM-1 and VCAM-1 in human lupus nephritis with advanced renal histological changes: preliminary findings.

Authors:  Mohamed Ismail Abd-Elkareem; Hegazy Mogahed Al Tamimy; Osama A Khamis; Salama S Abdellatif; Mahmoud Rezk Abdelwahed Hussein
Journal:  Clin Exp Nephrol       Date:  2010-08-17       Impact factor: 2.801

3.  Imbalances in serum proinflammatory cytokines and their soluble receptors: a putative role in the progression of idiopathic IgA nephropathy (IgAN) and Henoch-Schönlein purpura nephritis, and a potential target of immunoglobulin therapy?

Authors:  G Rostoker; J C Rymer; G Bagnard; M Petit-Phar; M Griuncelli; Y Pilatte
Journal:  Clin Exp Immunol       Date:  1998-12       Impact factor: 4.330

4.  Overexpression of interleukin-12 and T helper 1 predominance in lupus nephritis.

Authors:  M Tucci; L Lombardi; H B Richards; F Dammacco; F Silvestris
Journal:  Clin Exp Immunol       Date:  2008-09-15       Impact factor: 4.330

Review 5.  Urine biomarkers in juvenile-onset SLE nephritis.

Authors:  Louise Watson; Michael W Beresford
Journal:  Pediatr Nephrol       Date:  2012-05-16       Impact factor: 3.714

6.  MPO-ANCA-positive IgA nephropathy successfully treated with tonsillectomy.

Authors:  Noriko Ogawa; Shozo Yano; Yuko Yamane; Masateru Nishiki; Toru Yamaguchi; Tatsuo Tsukamoto; Eri Muso; Toshitsugu Sugimoto
Journal:  Clin Exp Nephrol       Date:  2007-12-21       Impact factor: 2.801

Review 7.  Inflammatory mechanisms of diabetic complications.

Authors:  Michael D Williams; Jerry L Nadler
Journal:  Curr Diab Rep       Date:  2007-06       Impact factor: 4.810

Review 8.  The role of cytokine in the lupus nephritis.

Authors:  Yasunori Iwata; Kengo Furuichi; Shuichi Kaneko; Takashi Wada
Journal:  J Biomed Biotechnol       Date:  2011-10-18

9.  Enhanced expression of the soluble form of E-selectin attenuates progression of lupus nephritis and vasculitis in MRL/lpr mice.

Authors:  Kimihiko Nakatani; Shuhei Yoshimoto; Osamu Asai; Hirokazu Sakan; Miho Terada; Yoshihiko Saito; Masato Nose; Masayuki Iwano; Noboru Konishi
Journal:  Immun Inflamm Dis       Date:  2013-10-30

10.  Clinical features of IgA nephropathy with serum ANCA positivity: a retrospective case-control study.

Authors:  Ya-Zi Yang; Su-Fang Shi; Yu-Qing Chen; Min Chen; Yi-He Yang; Xin-Fang Xie; Rong Zou; Ji-Cheng Lv; Li-Jun Liu; Hong Zhang
Journal:  Clin Kidney J       Date:  2015-08-30
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.